威尔森氏症－2025年至2031年全球市占率及排名、总收入及需求预测

2024 年威尔逊氏症全球市场规模估计为 2.21 亿美元，预计到 2031 年将调整至 2.94 亿美元，在 2025-2031 年预测期内的复合年增长率为 4.2%。

威尔森氏症，又称进行性豆状核变性或肝豆状核变性，会导致体内铜中毒。铜是细胞功能必需的元素，但过量的铜具有剧毒，可永久损害人体细胞功能。威尔逊氏症是由体内铜过度积聚引起的。正常情况下，饮食中的铜会释放到胆汁中，经由肝臟净化后，经由消化道排放体外。当过量的铜在大脑、肝臟和其他身体组织中积聚时，就会发生威尔森氏症。根据美国肝病研究协会统计，威尔逊氏症在全球范围内均有发生，发生率约每百万人30例。

威尔逊氏症市场的主要驱动力在于公众意识的提高和诊断能力的提升，使得这种罕见遗传疾病能够被早期发现。基因和生化检测技术的进步实现了及时诊断，从而能够更早地进行干预并更好地管理疾病。此外，对基因疗法和RNA干扰（RNAi）等新型治疗方法的研发投入不断增加，可望提供更有效、更毒性的治疗方法方案，进而推动市场成长。不断上涨的医疗成本和不断扩大的患者援助计划也有助于提高患者获得治疗的机会。

儘管取得了这些进展，威尔逊氏症市场仍面临诸多挑战，包括该疾病罕见，这限制了患者数量，并降低了大规模药物研发的奖励。现有治疗方法，例如螯合剂和锌疗法，通常存在副作用，且需要终身服药，导致患者依从性问题。新治疗方法的高成本、监管障碍以及需要更全面的临床试验也阻碍了市场成长。此外，某些地区医护人员和患者对此疾病的认知不足，可能导致诊断和治疗延误，进一步加剧疾病管理的复杂性。

本报告旨在提供有关全球威尔逊氏病市场的全面信息，重点关注总收入、市场份额和主要企业的排名，并按地区、国家、类型和应用进行分析。

本报告以百万美元为单位，提供威尔逊氏症市场规模、估算和预测数据，涵盖2020年至2031年的历史数据和预测数据，并以2024年为基准年。定量和定性分析将帮助读者制定业务/成长策略，评估市场竞争格局，分析公司在当前市场中的地位，并就威尔逊氏症做出明智的商业决策。

市场区隔

公司

• Bausch Health
• Teva
• ANI Pharmaceuticals
• Tsumura
• MSN Laboratories
• Kadmon Holdings
• Orphalan
• Endo International
• Univar Solutions
• APOTEX
• Sinepharm
• Taj Pharmaceutical

按类型分類的细分市场

• 三点一
• Penicillamine
• 其他的

应用领域

• 医院
• 药局
• 其他的

按地区

• 北美洲
  • 美国
  • 加拿大
• 亚太地区
  • 中国
  • 日本
  • 韩国
  • 东南亚
  • 印度
  • 澳洲
  • 亚太其他地区
• 欧洲
  • 德国
  • 法国
  • 英国
  • 义大利
  • 荷兰
  • 北欧国家
  • 其他欧洲
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 土耳其
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东和非洲地区

The global market for Wilson's Disease was estimated to be worth US$ 221 million in 2024 and is forecast to a readjusted size of US$ 294 million by 2031 with a CAGR of 4.2% during the forecast period 2025-2031.

Wilson's disease is also known as progressive lenticular degeneration and hepatolenticular degeneration that causes copper poisoning in the body. Copper is a necessary element for cellular functions; however, excessive copper is extremely toxic and can cause permanent damage to cellular functions of body. Wilson's disease is caused by excessive deposition of copper in the body. Generally, copper is released into bile from the diet is cleaned out by the liver, flowing out of the body from the gastrointestinal tract. Wilson's disease occurs due to excessive deposition of copper in the brain, liver, and other tissues of the body. According to the American Association for the Study of Liver Diseases, Wilson's disease occurs worldwide with prevalence of approximately 30 individuals affected per million.

The Wilson's Disease market is primarily driven by increasing awareness and improved diagnostic capabilities that enable earlier detection of this rare genetic disorder. Advances in genetic testing and biochemical assays have facilitated timely diagnosis, allowing for earlier intervention and better management of the disease. Additionally, growing investment in research and development of novel therapies, including gene therapy and RNA interference (RNAi), is fueling market growth by offering the potential for more effective and less toxic treatment options. Rising healthcare expenditure and expanding patient support programs also contribute to the increasing accessibility of treatment.

Despite advancements, the Wilson's Disease market faces significant challenges, including the rarity of the condition, which limits patient populations and reduces incentives for extensive drug development. Existing treatments, such as chelating agents and zinc therapies, often have side effects and require lifelong adherence, leading to compliance issues. High costs associated with emerging therapies, regulatory hurdles, and the need for more comprehensive clinical trials also pose barriers to market growth. Moreover, limited awareness among healthcare providers and patients in certain regions can delay diagnosis and treatment initiation, further complicating disease management.

This report aims to provide a comprehensive presentation of the global market for Wilson's Disease, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Wilson's Disease by region & country, by Type, and by Application.

The Wilson's Disease market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Wilson's Disease.

Market Segmentation

By Company

• Bausch Health
• Teva
• ANI Pharmaceuticals
• Tsumura
• MSN Laboratories
• Kadmon Holdings
• Orphalan
• Endo International
• Univar Solutions
• APOTEX
• Sinepharm
• Taj Pharmaceutical

Segment by Type

• Trientine
• Penicillamine
• Others

Segment by Application

• Hospital
• Drugs Stores
• Others

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Wilson's Disease company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Wilson's Disease in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Wilson's Disease in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Wilson's Disease Product Introduction
• 1.2 Global Wilson's Disease Market Size Forecast (2020-2031)
• 1.3 Wilson's Disease Market Trends & Drivers
  • 1.3.1 Wilson's Disease Industry Trends
  • 1.3.2 Wilson's Disease Market Drivers & Opportunity
  • 1.3.3 Wilson's Disease Market Challenges
  • 1.3.4 Wilson's Disease Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Wilson's Disease Players Revenue Ranking (2024)
• 2.2 Global Wilson's Disease Revenue by Company (2020-2025)
• 2.3 Key Companies Wilson's Disease Manufacturing Base Distribution and Headquarters
• 2.4 Key Companies Wilson's Disease Product Offered
• 2.5 Key Companies Time to Begin Mass Production of Wilson's Disease
• 2.6 Wilson's Disease Market Competitive Analysis
  • 2.6.1 Wilson's Disease Market Concentration Rate (2020-2025)
  • 2.6.2 Global 5 and 10 Largest Companies by Wilson's Disease Revenue in 2024
  • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Wilson's Disease as of 2024)
• 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Trientine
  • 3.1.2 Penicillamine
  • 3.1.3 Others
• 3.2 Global Wilson's Disease Sales Value by Type
  • 3.2.1 Global Wilson's Disease Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Wilson's Disease Sales Value, by Type (2020-2031)
  • 3.2.3 Global Wilson's Disease Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Hospital
  • 4.1.2 Drugs Stores
  • 4.1.3 Others
• 4.2 Global Wilson's Disease Sales Value by Application
  • 4.2.1 Global Wilson's Disease Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Wilson's Disease Sales Value, by Application (2020-2031)
  • 4.2.3 Global Wilson's Disease Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

• 5.1 Global Wilson's Disease Sales Value by Region
  • 5.1.1 Global Wilson's Disease Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Wilson's Disease Sales Value by Region (2020-2025)
  • 5.1.3 Global Wilson's Disease Sales Value by Region (2026-2031)
  • 5.1.4 Global Wilson's Disease Sales Value by Region (%), (2020-2031)
• 5.2 North America
  • 5.2.1 North America Wilson's Disease Sales Value, 2020-2031
  • 5.2.2 North America Wilson's Disease Sales Value by Country (%), 2024 VS 2031
• 5.3 Europe
  • 5.3.1 Europe Wilson's Disease Sales Value, 2020-2031
  • 5.3.2 Europe Wilson's Disease Sales Value by Country (%), 2024 VS 2031
• 5.4 Asia Pacific
  • 5.4.1 Asia Pacific Wilson's Disease Sales Value, 2020-2031
  • 5.4.2 Asia Pacific Wilson's Disease Sales Value by Region (%), 2024 VS 2031
• 5.5 South America
  • 5.5.1 South America Wilson's Disease Sales Value, 2020-2031
  • 5.5.2 South America Wilson's Disease Sales Value by Country (%), 2024 VS 2031
• 5.6 Middle East & Africa
  • 5.6.1 Middle East & Africa Wilson's Disease Sales Value, 2020-2031
  • 5.6.2 Middle East & Africa Wilson's Disease Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Wilson's Disease Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Wilson's Disease Sales Value, 2020-2031
• 6.3 United States
  • 6.3.1 United States Wilson's Disease Sales Value, 2020-2031
  • 6.3.2 United States Wilson's Disease Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Wilson's Disease Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Wilson's Disease Sales Value, 2020-2031
  • 6.4.2 Europe Wilson's Disease Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Wilson's Disease Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Wilson's Disease Sales Value, 2020-2031
  • 6.5.2 China Wilson's Disease Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Wilson's Disease Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Wilson's Disease Sales Value, 2020-2031
  • 6.6.2 Japan Wilson's Disease Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Wilson's Disease Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Wilson's Disease Sales Value, 2020-2031
  • 6.7.2 South Korea Wilson's Disease Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Wilson's Disease Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Wilson's Disease Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Wilson's Disease Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Wilson's Disease Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Wilson's Disease Sales Value, 2020-2031
  • 6.9.2 India Wilson's Disease Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Wilson's Disease Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Bausch Health
  • 7.1.1 Bausch Health Profile
  • 7.1.2 Bausch Health Main Business
  • 7.1.3 Bausch Health Wilson's Disease Products, Services and Solutions
  • 7.1.4 Bausch Health Wilson's Disease Revenue (US$ Million) & (2020-2025)
  • 7.1.5 Bausch Health Recent Developments
• 7.2 Teva
  • 7.2.1 Teva Profile
  • 7.2.2 Teva Main Business
  • 7.2.3 Teva Wilson's Disease Products, Services and Solutions
  • 7.2.4 Teva Wilson's Disease Revenue (US$ Million) & (2020-2025)
  • 7.2.5 Teva Recent Developments
• 7.3 ANI Pharmaceuticals
  • 7.3.1 ANI Pharmaceuticals Profile
  • 7.3.2 ANI Pharmaceuticals Main Business
  • 7.3.3 ANI Pharmaceuticals Wilson's Disease Products, Services and Solutions
  • 7.3.4 ANI Pharmaceuticals Wilson's Disease Revenue (US$ Million) & (2020-2025)
  • 7.3.5 ANI Pharmaceuticals Recent Developments
• 7.4 Tsumura
  • 7.4.1 Tsumura Profile
  • 7.4.2 Tsumura Main Business
  • 7.4.3 Tsumura Wilson's Disease Products, Services and Solutions
  • 7.4.4 Tsumura Wilson's Disease Revenue (US$ Million) & (2020-2025)
  • 7.4.5 Tsumura Recent Developments
• 7.5 MSN Laboratories
  • 7.5.1 MSN Laboratories Profile
  • 7.5.2 MSN Laboratories Main Business
  • 7.5.3 MSN Laboratories Wilson's Disease Products, Services and Solutions
  • 7.5.4 MSN Laboratories Wilson's Disease Revenue (US$ Million) & (2020-2025)
  • 7.5.5 MSN Laboratories Recent Developments
• 7.6 Kadmon Holdings
  • 7.6.1 Kadmon Holdings Profile
  • 7.6.2 Kadmon Holdings Main Business
  • 7.6.3 Kadmon Holdings Wilson's Disease Products, Services and Solutions
  • 7.6.4 Kadmon Holdings Wilson's Disease Revenue (US$ Million) & (2020-2025)
  • 7.6.5 Kadmon Holdings Recent Developments
• 7.7 Orphalan
  • 7.7.1 Orphalan Profile
  • 7.7.2 Orphalan Main Business
  • 7.7.3 Orphalan Wilson's Disease Products, Services and Solutions
  • 7.7.4 Orphalan Wilson's Disease Revenue (US$ Million) & (2020-2025)
  • 7.7.5 Orphalan Recent Developments
• 7.8 Endo International
  • 7.8.1 Endo International Profile
  • 7.8.2 Endo International Main Business
  • 7.8.3 Endo International Wilson's Disease Products, Services and Solutions
  • 7.8.4 Endo International Wilson's Disease Revenue (US$ Million) & (2020-2025)
  • 7.8.5 Endo International Recent Developments
• 7.9 Univar Solutions
  • 7.9.1 Univar Solutions Profile
  • 7.9.2 Univar Solutions Main Business
  • 7.9.3 Univar Solutions Wilson's Disease Products, Services and Solutions
  • 7.9.4 Univar Solutions Wilson's Disease Revenue (US$ Million) & (2020-2025)
  • 7.9.5 Univar Solutions Recent Developments
• 7.10 APOTEX
  • 7.10.1 APOTEX Profile
  • 7.10.2 APOTEX Main Business
  • 7.10.3 APOTEX Wilson's Disease Products, Services and Solutions
  • 7.10.4 APOTEX Wilson's Disease Revenue (US$ Million) & (2020-2025)
  • 7.10.5 APOTEX Recent Developments
• 7.11 Sinepharm
  • 7.11.1 Sinepharm Profile
  • 7.11.2 Sinepharm Main Business
  • 7.11.3 Sinepharm Wilson's Disease Products, Services and Solutions
  • 7.11.4 Sinepharm Wilson's Disease Revenue (US$ Million) & (2020-2025)
  • 7.11.5 Sinepharm Recent Developments
• 7.12 Taj Pharmaceutical
  • 7.12.1 Taj Pharmaceutical Profile
  • 7.12.2 Taj Pharmaceutical Main Business
  • 7.12.3 Taj Pharmaceutical Wilson's Disease Products, Services and Solutions
  • 7.12.4 Taj Pharmaceutical Wilson's Disease Revenue (US$ Million) & (2020-2025)
  • 7.12.5 Taj Pharmaceutical Recent Developments

8 Industry Chain Analysis

• 8.1 Wilson's Disease Industrial Chain
• 8.2 Wilson's Disease Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Wilson's Disease Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Wilson's Disease Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer

List of Tables

• Table 1. Wilson's Disease Market Trends
• Table 2. Wilson's Disease Market Drivers & Opportunity
• Table 3. Wilson's Disease Market Challenges
• Table 4. Wilson's Disease Market Restraints
• Table 5. Global Wilson's Disease Revenue by Company (2020-2025) & (US$ Million)
• Table 6. Global Wilson's Disease Revenue Market Share by Company (2020-2025)
• Table 7. Key Companies Wilson's Disease Manufacturing Base Distribution and Headquarters
• Table 8. Key Companies Wilson's Disease Product Type
• Table 9. Key Companies Time to Begin Mass Production of Wilson's Disease
• Table 10. Global Wilson's Disease Companies Market Concentration Ratio (CR5 and HHI)
• Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Wilson's Disease as of 2024)
• Table 12. Mergers & Acquisitions, Expansion Plans
• Table 13. Global Wilson's Disease Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
• Table 14. Global Wilson's Disease Sales Value by Type (2020-2025) & (US$ Million)
• Table 15. Global Wilson's Disease Sales Value by Type (2026-2031) & (US$ Million)
• Table 16. Global Wilson's Disease Sales Market Share in Value by Type (2020-2025)
• Table 17. Global Wilson's Disease Sales Market Share in Value by Type (2026-2031)
• Table 18. Global Wilson's Disease Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
• Table 19. Global Wilson's Disease Sales Value by Application (2020-2025) & (US$ Million)
• Table 20. Global Wilson's Disease Sales Value by Application (2026-2031) & (US$ Million)
• Table 21. Global Wilson's Disease Sales Market Share in Value by Application (2020-2025)
• Table 22. Global Wilson's Disease Sales Market Share in Value by Application (2026-2031)
• Table 23. Global Wilson's Disease Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
• Table 24. Global Wilson's Disease Sales Value by Region (2020-2025) & (US$ Million)
• Table 25. Global Wilson's Disease Sales Value by Region (2026-2031) & (US$ Million)
• Table 26. Global Wilson's Disease Sales Value by Region (2020-2025) & (%)
• Table 27. Global Wilson's Disease Sales Value by Region (2026-2031) & (%)
• Table 28. Key Countries/Regions Wilson's Disease Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
• Table 29. Key Countries/Regions Wilson's Disease Sales Value, (2020-2025) & (US$ Million)
• Table 30. Key Countries/Regions Wilson's Disease Sales Value, (2026-2031) & (US$ Million)
• Table 31. Bausch Health Basic Information List
• Table 32. Bausch Health Description and Business Overview
• Table 33. Bausch Health Wilson's Disease Products, Services and Solutions
• Table 34. Revenue (US$ Million) in Wilson's Disease Business of Bausch Health (2020-2025)
• Table 35. Bausch Health Recent Developments
• Table 36. Teva Basic Information List
• Table 37. Teva Description and Business Overview
• Table 38. Teva Wilson's Disease Products, Services and Solutions
• Table 39. Revenue (US$ Million) in Wilson's Disease Business of Teva (2020-2025)
• Table 40. Teva Recent Developments
• Table 41. ANI Pharmaceuticals Basic Information List
• Table 42. ANI Pharmaceuticals Description and Business Overview
• Table 43. ANI Pharmaceuticals Wilson's Disease Products, Services and Solutions
• Table 44. Revenue (US$ Million) in Wilson's Disease Business of ANI Pharmaceuticals (2020-2025)
• Table 45. ANI Pharmaceuticals Recent Developments
• Table 46. Tsumura Basic Information List
• Table 47. Tsumura Description and Business Overview
• Table 48. Tsumura Wilson's Disease Products, Services and Solutions
• Table 49. Revenue (US$ Million) in Wilson's Disease Business of Tsumura (2020-2025)
• Table 50. Tsumura Recent Developments
• Table 51. MSN Laboratories Basic Information List
• Table 52. MSN Laboratories Description and Business Overview
• Table 53. MSN Laboratories Wilson's Disease Products, Services and Solutions
• Table 54. Revenue (US$ Million) in Wilson's Disease Business of MSN Laboratories (2020-2025)
• Table 55. MSN Laboratories Recent Developments
• Table 56. Kadmon Holdings Basic Information List
• Table 57. Kadmon Holdings Description and Business Overview
• Table 58. Kadmon Holdings Wilson's Disease Products, Services and Solutions
• Table 59. Revenue (US$ Million) in Wilson's Disease Business of Kadmon Holdings (2020-2025)
• Table 60. Kadmon Holdings Recent Developments
• Table 61. Orphalan Basic Information List
• Table 62. Orphalan Description and Business Overview
• Table 63. Orphalan Wilson's Disease Products, Services and Solutions
• Table 64. Revenue (US$ Million) in Wilson's Disease Business of Orphalan (2020-2025)
• Table 65. Orphalan Recent Developments
• Table 66. Endo International Basic Information List
• Table 67. Endo International Description and Business Overview
• Table 68. Endo International Wilson's Disease Products, Services and Solutions
• Table 69. Revenue (US$ Million) in Wilson's Disease Business of Endo International (2020-2025)
• Table 70. Endo International Recent Developments
• Table 71. Univar Solutions Basic Information List
• Table 72. Univar Solutions Description and Business Overview
• Table 73. Univar Solutions Wilson's Disease Products, Services and Solutions
• Table 74. Revenue (US$ Million) in Wilson's Disease Business of Univar Solutions (2020-2025)
• Table 75. Univar Solutions Recent Developments
• Table 76. APOTEX Basic Information List
• Table 77. APOTEX Description and Business Overview
• Table 78. APOTEX Wilson's Disease Products, Services and Solutions
• Table 79. Revenue (US$ Million) in Wilson's Disease Business of APOTEX (2020-2025)
• Table 80. APOTEX Recent Developments
• Table 81. Sinepharm Basic Information List
• Table 82. Sinepharm Description and Business Overview
• Table 83. Sinepharm Wilson's Disease Products, Services and Solutions
• Table 84. Revenue (US$ Million) in Wilson's Disease Business of Sinepharm (2020-2025)
• Table 85. Sinepharm Recent Developments
• Table 86. Taj Pharmaceutical Basic Information List
• Table 87. Taj Pharmaceutical Description and Business Overview
• Table 88. Taj Pharmaceutical Wilson's Disease Products, Services and Solutions
• Table 89. Revenue (US$ Million) in Wilson's Disease Business of Taj Pharmaceutical (2020-2025)
• Table 90. Taj Pharmaceutical Recent Developments
• Table 91. Key Raw Materials Lists
• Table 92. Raw Materials Key Suppliers Lists
• Table 93. Wilson's Disease Downstream Customers
• Table 94. Wilson's Disease Distributors List
• Table 95. Research Programs/Design for This Report
• Table 96. Key Data Information from Secondary Sources
• Table 97. Key Data Information from Primary Sources

List of Figures

• Figure 1. Wilson's Disease Product Picture
• Figure 2. Global Wilson's Disease Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
• Figure 3. Global Wilson's Disease Sales Value (2020-2031) & (US$ Million)
• Figure 4. Wilson's Disease Report Years Considered
• Figure 5. Global Wilson's Disease Players Revenue Ranking (2024) & (US$ Million)
• Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Wilson's Disease Revenue in 2024
• Figure 7. Wilson's Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
• Figure 8. Trientine Picture
• Figure 9. Penicillamine Picture
• Figure 10. Others Picture
• Figure 11. Global Wilson's Disease Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
• Figure 12. Global Wilson's Disease Sales Value Market Share by Type, 2024 & 2031
• Figure 13. Product Picture of Hospital
• Figure 14. Product Picture of Drugs Stores
• Figure 15. Product Picture of Others
• Figure 16. Global Wilson's Disease Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
• Figure 17. Global Wilson's Disease Sales Value Market Share by Application, 2024 & 2031
• Figure 18. North America Wilson's Disease Sales Value (2020-2031) & (US$ Million)
• Figure 19. North America Wilson's Disease Sales Value by Country (%), 2024 VS 2031
• Figure 20. Europe Wilson's Disease Sales Value, (2020-2031) & (US$ Million)
• Figure 21. Europe Wilson's Disease Sales Value by Country (%), 2024 VS 2031
• Figure 22. Asia Pacific Wilson's Disease Sales Value, (2020-2031) & (US$ Million)
• Figure 23. Asia Pacific Wilson's Disease Sales Value by Region (%), 2024 VS 2031
• Figure 24. South America Wilson's Disease Sales Value, (2020-2031) & (US$ Million)
• Figure 25. South America Wilson's Disease Sales Value by Country (%), 2024 VS 2031
• Figure 26. Middle East & Africa Wilson's Disease Sales Value, (2020-2031) & (US$ Million)
• Figure 27. Middle East & Africa Wilson's Disease Sales Value by Country (%), 2024 VS 2031
• Figure 28. Key Countries/Regions Wilson's Disease Sales Value (%), (2020-2031)
• Figure 29. United States Wilson's Disease Sales Value, (2020-2031) & (US$ Million)
• Figure 30. United States Wilson's Disease Sales Value by Type (%), 2024 VS 2031
• Figure 31. United States Wilson's Disease Sales Value by Application (%), 2024 VS 2031
• Figure 32. Europe Wilson's Disease Sales Value, (2020-2031) & (US$ Million)
• Figure 33. Europe Wilson's Disease Sales Value by Type (%), 2024 VS 2031
• Figure 34. Europe Wilson's Disease Sales Value by Application (%), 2024 VS 2031
• Figure 35. China Wilson's Disease Sales Value, (2020-2031) & (US$ Million)
• Figure 36. China Wilson's Disease Sales Value by Type (%), 2024 VS 2031
• Figure 37. China Wilson's Disease Sales Value by Application (%), 2024 VS 2031
• Figure 38. Japan Wilson's Disease Sales Value, (2020-2031) & (US$ Million)
• Figure 39. Japan Wilson's Disease Sales Value by Type (%), 2024 VS 2031
• Figure 40. Japan Wilson's Disease Sales Value by Application (%), 2024 VS 2031
• Figure 41. South Korea Wilson's Disease Sales Value, (2020-2031) & (US$ Million)
• Figure 42. South Korea Wilson's Disease Sales Value by Type (%), 2024 VS 2031
• Figure 43. South Korea Wilson's Disease Sales Value by Application (%), 2024 VS 2031
• Figure 44. Southeast Asia Wilson's Disease Sales Value, (2020-2031) & (US$ Million)
• Figure 45. Southeast Asia Wilson's Disease Sales Value by Type (%), 2024 VS 2031
• Figure 46. Southeast Asia Wilson's Disease Sales Value by Application (%), 2024 VS 2031
• Figure 47. India Wilson's Disease Sales Value, (2020-2031) & (US$ Million)
• Figure 48. India Wilson's Disease Sales Value by Type (%), 2024 VS 2031
• Figure 49. India Wilson's Disease Sales Value by Application (%), 2024 VS 2031
• Figure 50. Wilson's Disease Industrial Chain
• Figure 51. Wilson's Disease Manufacturing Cost Structure
• Figure 52. Channels of Distribution (Direct Sales, and Distribution)
• Figure 53. Bottom-up and Top-down Approaches for This Report
• Figure 54. Data Triangulation
• Figure 55. Key Executives Interviewed